Birzeit Pharmaceuticals Company announced unaudited consolidated preliminary financial results for year ended December 31, 2013. For the period, the company's net profit after taxes reached $5,480,204, compared with a net profit after taxes of $4,785,914 in the audited data for 2012, a net increase of 14.5%.